111 (YI) EBIT Growth (3y) (2020 - 2025)
111 (YI) EBIT Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 29.94% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 26.79% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -3.82% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 1.32% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 85.70% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 20.42% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -1.40% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 66.97% |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 6.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 85.70% |
| Sep 30, 2025 | 69.93% |
| Jun 30, 2025 | 26.01% |
| Mar 31, 2025 | 26.02% |
| Dec 31, 2024 | 60.62% |
| Sep 30, 2024 | 26.25% |
| Jun 30, 2024 | 26.32% |
| Mar 31, 2024 | 26.40% |
| Dec 31, 2023 | -9.46% |
| Sep 30, 2023 | 14.28% |
| Jun 30, 2023 | 24.15% |
| Mar 31, 2023 | 42.09% |
| Dec 31, 2022 | -38.40% |
| Sep 30, 2022 | -39.49% |
| Jun 30, 2022 | 6.50% |
| Mar 31, 2022 | -0.72% |
| Dec 31, 2021 | -41.85% |
| Sep 30, 2021 | -50.94% |
| Jun 30, 2021 | -24.67% |
| Mar 31, 2021 | -59.16% |